Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
A stock index measures the performance of a defined group of stocks, reflecting overall market or segment trends for comparison.
20,961 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
AMD's growth story is gaining steam as data centers, AI workloads, and CPU/GPU innovations align. This guide breaks d...
SpaceX has sprinted out of the gate after its IPO, up roughly 49% from the offer price. As December approaches, inves...
Rivian shares traded near $14.90 as macro headwinds pressure EV names, while a still-growing VW software venture keep...
Short sellers now hold about 31% of SpaceX’s tradable float, a level that could ignite a volatile squeeze unless the ...
Vertex’s $10 billion cash bid for Crinetics sparked a sharp rally, lifting the stock nearly to the offer price as tra...
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
GameStop outperforms other meme stocks in 2026, climbing as speculative bets and buyout chatter around Ryan Cohen fue...
Oil has crossed the $100 mark, creating income opportunities in energy. Here are two no-brainer energy dividend stock...
Apple faces a window of opportunity as upbeat quarterly results and expanding services/supporting growth drivers push...
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
Two leading banks issued contrasting views on AMD in a single day, underscoring a broader divide in how investors pri...